/
Vernon D. Toelle, Ph.D. Team Leader Vernon D. Toelle, Ph.D. Team Leader

Vernon D. Toelle, Ph.D. Team Leader - PowerPoint Presentation

ani
ani . @ani
Follow
27 views
Uploaded On 2024-02-02

Vernon D. Toelle, Ph.D. Team Leader - PPT Presentation

PreMarket Compliance and Administrative Actions Team BIMO Team Overview of CVM Bioresearch Monitoring An Agencywide inspectional process focused on data quality of safety and efficacy studies These studies are submitted during the approvalreview process for food and medical products reg ID: 1043779

inspections bimo review food bimo inspections food review cvm field team studies data approval safety fda compliance animals processing

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Vernon D. Toelle, Ph.D. Team Leader" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. Vernon D. Toelle, Ph.D.Team LeaderPre-Market Compliance and Administrative Actions Team(BIMO Team)Overview of CVM Bioresearch Monitoring

2. An Agency-wide inspectional process focused on data quality of safety and efficacy studies. These studies are submitted during the approval/review process for food and medical products regulated by FDA.Inspections of non-clinical safety studies in the late 1970s became impetus for the development of the BIMO processesBioresearch Monitoring (BIMO)

3. Compliance programs for which CVM issues inspectional assignments are: Clinical Investigator (CI), Good Laboratory Practice (GLP) and Sponsors, Contract Research Organizations and Monitors (S/M). BIMO Compliance Programs

4. Inspections of Studies can occur in 7 major species :Horses, Cats, Dogs – Non-Food animals.Cattle (Dairy and Beef), Swine, Chicken, Turkeys – Food animals.Can also occur in minor speciesAquaculture, other birds (poultry) and other petsOverview of CVM’s BIMO Program (cont.)

5. Animal Feeds, Production Drugs, Therapeutic for Food Animals, Therapeutic for Non-Food Animals, and Human Food Safety Divisions in CVM can all request BIMO inspections to be conducted for studies they are currently or about to review. Other review oriented groups can request inspections as well.Overview of CVM’s BIMO Program (cont.)

6. We do not regulate Animal Vaccines (USDA does, 9 CFR 100) used in disease immunization, but we do regulate “other” biologics as drugs. No pre-approval requirements for Veterinary DevicesProduction Drugs -- products marketed to enhance economic performanceOther Relevant Issues

7. Directed CI assignments requests are initiated from the review divisions and sent to BIMO team for processing.Can be “real-time” or data audit requestsSurveillance Sponsor/Monitor assignments are initiated by BIMO team.Input sought from review divisionsAssignments are tracked in ORA field and CVM databases.CVM Assignment Processing

8. 5 Regions, 20 District OfficesCVM BIMO inspections are distributed disproportionally across the USA. More inspections tend to happen in Southwest and Central Region areas (more animal agriculture in those areas) than other Regions.BIMO monitors in each district manage workloadOffice of Regulatory Affairs (i.e. The Field)

9.

10. Protocols usually providedDrug shipment notices A Drug sponsor’s submitted reportsFinal reportsRaw/source dataDocuments sent to Field with an Assignment

11. A field Consumer Safety Officer (CSO) typically conducts an inspection at a site (CI, GLP, or S/M) for ~ one week.If there are objectionable conditions (i.e. violations of the regulations) the CSO can issue a form 483.An Establishment Inspection Report (EIR) is written regardless of whether a 483 is issued.ORA Field Inspections

12. Initial review conducted by BIMO teamScientific reviews conducted by pre-approval divisions.Reviewers recommend a classificationEIRs used to determine data acceptability for approval packages (NADAs).Final Classifications determined by BIMO teamEIR processing in CVM

13. Study Data RejectionUntitled and Warning LettersDisqualificationApplication Integrity PolicyBIMO Administrative and Regulatory Actions

14. http://www.fda.gov/ICECI/EnforcementActions/BioresearchMonitoring/default.htmBIMO General Itemshttp://www.fda.gov/ICECI/ComplianceManuals/ComplianceProgramManual/ucm255614.htmBIMO Compliance ProgramsHelpful FDA BIMO Weblinks